Dose-dependent activation of gene expression is achieved using CRISPR and small molecules that recruit endogenous chromatin machinery

Journal: Nature Biotechnology

Published: 2019-11-11

DOI: 10.1038/s41587-019-0296-7

Affiliations: 8

Authors: 10

Go to article
Institutions Share
NIH NCI Oncogenomics Section, United States of America (USA) 0.25
UNC Division of Chemical Biology and Medicinal Chemistry (CBMC), United States of America (USA) 0.20
UNC Center for Integrative Chemical Biology and Drug Discovery (CICBDD), United States of America (USA) 0.20
Center for Therapeutics Discovery, ISMMS, United States of America (USA) 0.08
Department of Pharmacological Sciences, ISMMS, United States of America (USA) 0.08
Department of Oncological Sciences, ISMMS, United States of America (USA) 0.08
Tisch Cancer Institute (TCI), ISMMS, United States of America (USA) 0.08
IRCCS Bambino Gesù Children's Hospital, Italy 0.05

Return

Except where otherwise noted © 2020 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER